<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36376797</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Kennedy's disease presented with mastication fatigue combined with positive titin antibody: a case report.</ArticleTitle><Pagination><StartPage>425</StartPage><MedlinePgn>425</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">425</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-022-02971-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Spinal and bulbar muscular atrophy (SBMA) is an X-linked recessive hereditary neuromuscular disorder caused by the expanded trinucleotide repeat in the androgen receptors gene. The major clinical manifestations of SBMA consist of weakness in the bulbar and limb muscles, fasciculations, tremors, cramps, sensory impairment, and gynecomastia. However, atypical SBMA cases may lead to misdiagnosis. Muscular fatigue and decremental responses to repetitive nerve stimulation (RNS), despite being observed in some SBMA patients, are usually occurred in MG patients, and patient with the symptom of mastication fatigue was rarely reported. In addition, cardiological investigations have been performed in SBMA patients and several ECG alterations were identified. Here we report an SBMA patient presenting with a rare onset symptom of mastication fatigue, who has been detected with a positive titin antibody in the serum and showed a WPW pattern electrocardiogram.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">The patient showed mildly progressive fatigue in the muscles of mastication over 3 years. Neurological examination showed facial muscle weakness and a wasting tongue with fasciculations, but the weakness, wasting, or fasciculations were not obvious in the limbs. 3-Hz RNS showed a decremental response in bilateral orbicularis oculi. The test of titin antibody was positive in the serum, and the electrocardiogram showed a WPW pattern ECG. Genetic analysis revealed an increased number (39 repeats) of tandem CAG repeats in the AR gene, which confirmed the diagnosis of SBMA. The fatigue symptom was significantly improved after oral pyridostigmine bromide treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This case calls for more attention to muscular fatigue as the onset symptoms of Kennedy's disease. ECG screening is of importance in SBMA patients and further studies are needed to investigate the titin antibody in SBMA patients as well as other neurogenic disorders.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ji</LastName><ForeName>Guang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cerebrovascular Disease and Spine Neurosurgery, The People's Hospital Of Guangxi Zhuang Autonomous Region, 530016, Nanning, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xiaomeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Cuifang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhenfei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xueqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, 050000, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yaling</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3635-1729</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei, People's Republic of China. lyldoctor1006@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurological Laboratory of Hebei Province, 050000, Shijiazhuang, Hebei, People's Republic of China. lyldoctor1006@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064211">Connectin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064211" MajorTopicYN="N">Connectin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008409" MajorTopicYN="N">Mastication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005207" MajorTopicYN="N">Fasciculation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mastication fatigue</Keyword><Keyword MajorTopicYN="N">Repetitive nerve stimulation</Keyword><Keyword MajorTopicYN="N">SBMA</Keyword><Keyword MajorTopicYN="N">Titin antibody</Keyword><Keyword MajorTopicYN="N">WPW syndrome</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>0</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36376797</ArticleId><ArticleId IdType="pmc">PMC9661787</ArticleId><ArticleId IdType="doi">10.1186/s12883-022-02971-0</ArticleId><ArticleId IdType="pii">10.1186/s12883-022-02971-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18(7):671&#x2013;80. doi: 10.1212/WNL.18.7.671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.18.7.671</ArticleId><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77&#x2013;9. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevic Z, et al. Myasthenic symptoms in a patient with Kennedy&#x2019;s disease. Acta Neurol Belg. 2014;114(1):71&#x2013;3. doi: 10.1007/s13760-013-0189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-013-0189-3</ArticleId><ArticleId IdType="pubmed">23444172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, et al. Decremental responses to repetitive nerve stimulation in x-linked bulbospinal muscular atrophy. J Clin Neurol. 2013;9(1):32&#x2013;5. doi: 10.3988/jcn.2013.9.1.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2013.9.1.32</ArticleId><ArticleId IdType="pmc">PMC3543907</ArticleId><ArticleId IdType="pubmed">23346158</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K, et al. Muscular fatigue and decremental response to repetitive nerve stimulation in X-linked spinobulbar muscular atrophy. Eur J Neurol. 2009;16(1):76&#x2013;80. doi: 10.1111/j.1468-1331.2008.02349.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02349.x</ArticleId><ArticleId IdType="pubmed">19087153</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada M, Inaba A, Shiojiri T. X-linked spinal and bulbar muscular atrophy with myasthenic symptoms. J Neurol Sci. 1997;146(2):183&#x2013;5. doi: 10.1016/S0022-510X(96)00303-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(96)00303-6</ArticleId><ArticleId IdType="pubmed">9077516</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki A, et al. Brugada syndrome in spinal and bulbar muscular atrophy. Neurology. 2014;82(20):1813&#x2013;21. doi: 10.1212/WNL.0000000000000434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000434</ArticleId><ArticleId IdType="pubmed">24759840</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, et al. Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients. J Neurol Neurosurg Psychiatry. 2016;87(8):810&#x2013;6. doi: 10.1136/jnnp-2015-311305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311305</ArticleId><ArticleId IdType="pmc">PMC4975824</ArticleId><ArticleId IdType="pubmed">26503015</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmetz K, et al. J wave syndromes in patients with spinal and bulbar muscular atrophy. J Neurol. 2022;269(7):3690&#x2013;3699. doi: 10.1007/s00415-022-10992-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-10992-5</ArticleId><ArticleId IdType="pmc">PMC9217903</ArticleId><ArticleId IdType="pubmed">35132468</ArticleId></ArticleIdList></Reference><Reference><Citation>Boz C, et al. Ocular myasthenia gravis associated with x-linked recessive spinal and bulbar muscular atrophy. J Clin Neuromuscul Dis. 2004;5(3):115&#x2013;8. doi: 10.1097/00131402-200403000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00131402-200403000-00001</ArticleId><ArticleId IdType="pubmed">19078730</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, O&#x2019;Bryant EL, Jordan CL. Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuromuscular junction. J Comp Neurol. 2004;473(1):59&#x2013;72. doi: 10.1002/cne.20088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20088</ArticleId><ArticleId IdType="pubmed">15067718</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilhus NE, et al. Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nat Rev Neurol. 2016;12(5):259&#x2013;68. doi: 10.1038/nrneurol.2016.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.44</ArticleId><ArticleId IdType="pubmed">27103470</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazaridis K, Tzartos SJ. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. Front Immunol. 2020;11:212. doi: 10.3389/fimmu.2020.00212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00212</ArticleId><ArticleId IdType="pmc">PMC7033452</ArticleId><ArticleId IdType="pubmed">32117321</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S, et al. Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021;92(10):1072&#x2013;9. doi: 10.1136/jnnp-2020-324615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324615</ArticleId><ArticleId IdType="pubmed">33737450</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchio N, et al. Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology. Neurol Neuroimmunol Neuroinflamm. 2019;6(2):e535. doi: 10.1212/NXI.0000000000000535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000535</ArticleId><ArticleId IdType="pmc">PMC6340335</ArticleId><ArticleId IdType="pubmed">30697585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhu JS, et al. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation. 2005;111(1):21&#x2013;9. doi: 10.1161/01.CIR.0000151291.32974.D5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000151291.32974.D5</ArticleId><ArticleId IdType="pmc">PMC2908313</ArticleId><ArticleId IdType="pubmed">15611370</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KP, et al. PRKAG3 polymorphisms associated with sporadic Wolff-Parkinson-White syndrome among a Taiwanese population. J Chin Med Assoc. 2016;79(12):656&#x2013;60. doi: 10.1016/j.jcma.2016.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcma.2016.08.008</ArticleId><ArticleId IdType="pubmed">27866917</ArticleId></ArticleIdList></Reference><Reference><Citation>Breza M, Koutsis G. Kennedy&#x2019;s disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. J Neurol. 2019;266(3):565&#x2013;73. doi: 10.1007/s00415-018-8968-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8968-7</ArticleId><ArticleId IdType="pubmed">30006721</ArticleId></ArticleIdList></Reference><Reference><Citation>Francini-Pesenti F, et al. Metabolic alterations in spinal and bulbar muscular atrophy. Rev Neurol (Paris) 2020;176(10):780&#x2013;7. doi: 10.1016/j.neurol.2020.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.03.020</ArticleId><ArticleId IdType="pubmed">32631678</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>